TherapeuticsMD, Inc. (TXMD)

TherapeuticsMD Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	19	24	53	151	330	656
Market Cap Growth	-25.61%	-55.04%	-64.97%	-54.24%	-49.70%	-27.59%
Enterprise Value	21	26	11	282	496	699
PE Ratio	-	-2.31	0.47	-0.88	-1.80	-3.73
PS Ratio	15.97	18.27	0.76	58.71	5.09	13.22
PB Ratio	0.67	0.81	1.51	-1.61	-2.66	71.32
P/FCF Ratio	-1.79	-0.49	-12.98	-1.06	-2.07	-3.90
P/OCF Ratio	-1.79	-0.49	-12.98	-1.06	-2.07	-3.96
EV/Sales Ratio	17.62	19.97	0.16	109.79	7.65	14.08
EV/EBITDA Ratio	-4.39	-2.77	0.10	-1.65	-3.29	-4.44
EV/EBIT Ratio	-3.78	-2.52	0.10	-1.64	-3.20	-4.40
EV/FCF Ratio	-1.93	-0.54	-2.69	-1.98	-3.11	-4.16
Debt / Equity Ratio	0.22	0.22	0.21	-2.10	-1.99	22.15
Debt / EBITDA Ratio	-0.98	-0.69	0.07	-1.14	-1.63	-1.29
Debt / FCF Ratio	-0.43	-0.14	-1.81	-1.38	-1.54	-1.21
Quick Ratio	1.17	1.08	1.05	0.26	1.91	3.49
Current Ratio	1.78	1.72	1.18	0.47	2.17	3.93
Asset Turnover	0.03	0.03	0.56	0.01	0.31	0.21
Interest Coverage	-	-	-	-	-5.42	-9.13
Return on Equity (ROE)	-25.30%	-34.10%	-249.20%	329.10%	193.50%	-1241.30%
Return on Assets (ROA)	-15.60%	-19.90%	88.90%	-83.20%	-88.10%	-74.60%
Return on Capital (ROIC)	-20.00%	-23.79%	2.80%	-77.48%	-127.11%	-70.99%
Earnings Yield	-38.70%	-43.20%	211.63%	-114.14%	-55.60%	-26.84%
FCF Yield	-76.92%	-202.32%	-7.71%	-94.48%	-48.37%	-25.63%
Buyback Yield / Dilution	-18.23%	-11.48%	-17.66%	-44.39%	-11.89%	-9.48%
Total Shareholder Return	-18.23%	-11.48%	-17.66%	-44.39%	-11.89%	-9.48%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).